EROSION Study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography–Based Management in Plaque Erosion) | Zendy

Lei Xing | Zendy; Erika Yamamoto | Zendy; Tomoyo Sugiyama | Zendy; Haibo Jia | Zendy; Lijia Ma | Zendy; Sining Hu | Zendy; Chao Wang | Zendy; Yingchun Zhu | Zendy; Lulu Li | Zendy; Maoen Xu | Zendy; Huimin Liu | Zendy; Krzysztof Bryniarski | Zendy; Jingbo Hou | Zendy; Shaosong Zhang | Zendy; Hang Lee | Zendy; Bo Yu | Zendy; IkKyung Jang | Zendy

Open Access

EROSION Study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography–Based Management in Plaque Erosion)

Author(s) -

Lei Xing,

Erika Yamamoto,

Tomoyo Sugiyama,

Haibo Jia,

Lijia Ma,

Sining Hu,

Chao Wang,

Yingchun Zhu,

Lulu Li,

Maoen Xu,

Huimin Liu,

Krzysztof Bryniarski,

Jingbo Hou,

Shaosong Zhang,

Hang Lee,

Bo Yu,

IkKyung Jang

Publication year - 2017

Publication title -

circulation cardiovascular interventions

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.117.005860

Subject(s) - medicine , acute coronary syndrome , cardiology , thrombus , optical coherence tomography , fibrous cap , revascularization , aspirin , adverse effect , radiology , myocardial infarction

The initial EROSION study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography-Based Management in Plaque Erosion) demonstrated that patients with acute coronary syndrome caused by plaque erosion might be stabilized with aspirin and ticagrelor without stenting for ≤1 month. However, a long-term evaluation of outcomes is lacking. The aim of this study was to assess whether the initial benefit of noninterventional therapy for patients with acute coronary syndrome caused by plaque erosion is maintained for ≤1 year.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research